Hologic Aktie

72,60USD -0,13USD -0,18%
Hologic für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 879100 / ISIN: US4364401012
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 98,57
The Vanguard Group, Inc. 12,20
Vanguard Group, Inc. (Subfiler) 11,42
T. Rowe Price Investment Management, Inc. 9,75
T. Rowe Price Investment Management, Inc. 9,75
T Rowe Price Mid Cap Growth Fund 4,63
State Street Corp. 4,59
Morgan Stanley Investment Management Ltd. 3,92
BlackRock Fund Advisors 3,76
Vanguard Total Stock Market ETF 3,24
Vanguard 500 Index Fund 2,71
Geode Capital Management LLC 2,46
BlackRock Institutional Trust Co. NA 2,27
Vanguard Mid Cap Index Fund 2,17
Fidelity Management & Research Co. LLC 2,16

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 5 814 6 705 6 944 6 990 7 063
Umsatz pro Mitarbeiter in Mio. EUR 0,65 0,84 0,70 0,58 0,57

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 2 222 3 169 3 862 4 185 3 823
Summe Anlagevermögen 4 974 5 751 5 209 4 955 5 333
Summe Aktiva 7 196 8 920 9 071 9 139 9 156

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 4 489 4 701 4 195 4 122 4 026
Summe Eigenkapital 2 707 4 219 4 876 5 017 5 130
Summe Passiva 7 196 8 920 9 071 9 139 9 156

Adresse

250 Campus Drive, 01752 Marlborough
Telefon +1 (508) 263-2900
Internet http://www.hologic.com

Management

Amy A. McBride-Wendell
Lead Independent Director
Benjamin J. Cohn
Vice President & Controller
Charles J. Dockendorff
Independent Director
Christiana Stamoulis
Independent Director
Diana de Walt
Senior Vice President-Global Human Resources
Essex D. Mitchell
Chief Operating Officer
Jan Verstreken
Group President-International
Jennifer Schneiders
President-Diagnostics Solutions
John M. Griffin
General Counsel
Karleen Marie Oberton
Chief Financial Officer
Ludwig N. Hantson
Independent Director
Mark W Irving
Secretary & Vice President
Martin D. Madaus
Director
Monica Aguirre Berthelot
Chief of Staff & Vice President
Nanaz Mohtashami
Independent Director
Paul Malenchini
Chief Information Officer
Ryan Simon
Vice President-Investor Relations
Sally W. Crawford
Independent Director
Scott Christensen
SVP-Global Supply Chain, Quality & Regulatory
Scott T. Garrett
Independent Director
Stacey D. Stewart
Independent Director
Stephen P. MacMillan
Chairman, President & Chief Executive Officer